Trial Profile
A trial to find the rate of urinary retention in clinical practice after treatment with Botulinum toxin A (BTN/A) for refractory overactive bladder (OAB) symptoms and determine factors that predict this outcome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 02 Jun 2016 New trial record